Neurology of the Cryopyrin-Associated Periodic Feversyndrome by unknown
ORAL PRESENTATION Open Access
Neurology of the Cryopyrin-Associated Periodic
Feversyndrome
T Parker1, S Keddie2, D Kidd2, M Maviki3, T Lane4, P Hawkins4, L Ginsberg1,2, H Lachmann4*
From 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases
Dresden, Germany. 30 September - 3 October 2015
Introduction
There are little data on the multiple neurological mani-
festations of CAPS in adult patients.
Objectives
To retrospectively analyse the neurological features of
CAPS in a cohort of adult patients treated at a single
UK centre.
Patients and methods
38 patients (aged 16-69 years) with confirmed CAPS and
on long term treatment with anti IL-1 agents were
included. All patients were reviewed annually by a neurol-
ogist, an ophthalmologist and had audiometry. 35 patients
had cranial MRIs, 4 patients had lumbar punctures.
Results
Ninety-five percent of our patients had neurological fea-
tures, with 84% describing some form of headache, 66%
having sensorineural hearing loss on audiometry, 60%
reporting myalgia, 34% having papilloedema during the
course of their illness and 26% having evidence of optic
atrophy. Twenty-five patients had normal MRI brain
scans. Six scans demonstrated T2 hyperintensities in the
subcortical white matter (in one case from prior ischaemic
insult). Incidental findings in 4 cases included: an ara-
chnoid cyst, an acoustic neuroma, a pineal cyst and a
meningioma. All lumbar punctures were consistent with
chronic meningitis. There was a marked response to phar-
macological interleukin-one-beta (IL-1b) inhibition, (29/32
patients with headache and 22/23 with myalgia respond-
ing). Patients with the T348M mutation (N= 8) tended to
have a more severe neurological phenotype with an earlier
age of onset, more hearing loss, papilloedema and optic
disc atrophy, the R260W mutation (N=8) was associated
with an intermediate severity phenotype, and A439V
(N=11) a relatively milder neurological phenotype.
Conclusion
This case series demonstrates a much higher prevalence of
neurological symptoms in CAPS than reported from
EUROFEVERS (Levy 2014) and highlights the importance
of increased awareness of CAPS amongst neurologists,
to aid diagnosis and allow implementation of the highly
targeted and effective therapies available.
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